Hepatic steatosis is a key component of NAFLD pathophysiology [36], requiring the coordination between peroxisome proliferator-activated receptor alpha (PPARα) and PPARγ to balance fatty acid synthesis and oxidation. This evidence concerns the gene PPARA and fatty liver disease.